Welcome To The Canadian Biomaterials Society!
The Canadian Biomaterials Society (CBS) is an incorporated, not-for-profit organization dedicated to the development of biomaterials science, technology, and education in Canadian universities, industry, and government. Become a member to get access to a variety of online member resources and student/post-doctoral fellow awards!
La Société canadienne des biomatériaux (SCB) est un organisme à but non lucratif constitué en société qui se consacre au développement de la science, de la technologie et de l'éducation en matière de biomatériaux au Canada. Devenez membre pour bénéficier de l’ensemble des informations du site et des bourses distribuées aux étudiants membres pour participer aux congrès.
Recent News
WBC 2020 Workshop Proposals (0 comments)
2019-06-12 18:14:39 by Todd Hoare
As you may have noticed already, the WBC2020 Executive Committee is calling for workshop proposals. We hereby would like to take this opportunity to encourage you to submit your proposals before the deadline of June 30th 2019...Next AGM on May 22nd (0 comments)
2019-05-07 13:04:44 by Sophie Lerouge
Dear CBS members, Our Annual General Meeting will take place during the CBS2019 on May 22nd, at 12 15 in the Suzor Room. You can find here the Agenda and the AGM 2018 Minutes. See you soon in Quebec City Sophie Lerouge, CBS PresidentSpring Newsletter (0 comments)
2019-05-07 12:52:42 by Sophie Lerouge
Dear CBS members, The CBS Spring Newsletter is now online, featuring information on the CBS2019 program, list of awardees and updates from student chapters. Enjoy Bonne lectureBiofabrication 2019 - Abstract deadline May17th (0 comments)
2019-05-07 06:13:39 by Sophie Lerouge
Dear CBS members, Please note the Biofabrication 2019, the annual meeting of the International Society of Biofabrication. The conference will take place at Ohio State University in Colombus in October 20-22, 2019...Total Results: 92
Last | Next | Page: 1 2 3 4 5 6 7 8 9 10
Biomaterial Highlight Of The Month
PAMAM dendrimer based formulation of haloperidol for brain targeting via intranasal delivery
Read More
